MedPath

Atlantic Pharmaceuticals Ltd.

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:3

Trial Phases

2 Phases

Phase 1:2
Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 3
2 (50.0%)

Phase 1 Food Effect Study for Alicaforsen Tablets

Phase 1
Completed
Conditions
IBD
Interventions
First Posted Date
2018-03-22
Last Posted Date
2018-11-07
Lead Sponsor
Atlantic Pharmaceuticals Ltd
Target Recruit Count
15
Registration Number
NCT03473626
Locations
🇬🇧

Phase 1 unit, Nottingham, United Kingdom

Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics

Phase 3
Completed
Conditions
Pouchitis
Interventions
Drug: Placebo
First Posted Date
2015-08-17
Last Posted Date
2020-02-25
Lead Sponsor
Atlantic Pharmaceuticals Ltd
Target Recruit Count
138
Registration Number
NCT02525523
Locations
🇺🇸

Site Reference ID/Investigator# 1008, La Jolla, California, United States

🇺🇸

Site Reference ID/Investigator # 1005, Los Angeles, California, United States

🇺🇸

Site Reference ID/Investigator#1011, Stanford, California, United States

and more 38 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.